Previous data suggested PIK3CA mutations in approximately 8% of HNSCC samples [37], but more recent data from TCGA study identified PIK3CA mutations in 21% of HNSCC samples, with 73% of the PIK3CA mutations localized to hotspots that promote activation [38]. The gene discussed is PIK3CA; the disease is head and neck squamous cell carcinoma.